Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jan 28, 2026
- Accession no.
- 0001673232-26-000007
- Filed
- Jan 28, 2026
- Trade date
- Jan 20-26, 2026
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 19 non-derivative transactions and 3 derivative transactions. Open-market sales total $14.3M. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Common Stock | MOption exerciseAcquired | +7,875 | $146.03 | +$1,149,986.25 | 7,875 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −63 | $456.87 | −$28,782.81 | 7,812 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −372 | $457.92 | −$170,346.24 | 7,440 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −377 | $458.74 | −$172,944.98 | 7,063 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −268 | $459.86 | −$123,242.48 | 6,795 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −271 | $461.12 | −$124,963.52 | 6,524 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −1,322 | $463.26 | −$612,429.72 | 5,202 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −1,225 | $464.06 | −$568,473.5 | 3,977 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −966 | $465.11 | −$449,296.26 | 3,011 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −568 | $466.06 | −$264,722.08 | 2,443 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −321 | $467.09 | −$149,935.89 | 2,122 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −1,573 | $468.12 | −$736,352.76 | 549 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −451 | $469.18 | −$211,600.18 | 98 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −84 | $470.37 | −$39,511.08 | 14 | Indirect | |
| Jan 20, 2026 | Common Stock | SSaleDisposed | −14 | $470.76 | −$6,590.64 | 0 | Indirect | |
| Jan 26, 2026 | Common Stock | MOption exerciseAcquired | +14,625 | $117.76 | +$1,722,240 | 14,625 | Indirect | |
| Jan 26, 2026 | Common Stock | SSaleDisposed | −14,625 | $471.91 | −$6,901,683.75 | 0 | Indirect | |
| Jan 26, 2026 | Common Stock | MOption exerciseAcquired | +7,875 | $146.03 | +$1,149,986.25 | 7,875 | Indirect | |
| Jan 26, 2026 | Common Stock | SSaleDisposed | −7,875 | $471.91 | −$3,716,291.25 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Common Stock | MOption exerciseDisposed | −7,875 | $0.00 | $0 | 36,565 | Indirect | |
| Jan 26, 2026 | Common Stock | MOption exerciseDisposed | −14,625 | $0.00 | $0 | 53,250 | Indirect | |
| Jan 26, 2026 | Common Stock | MOption exerciseDisposed | −7,875 | $0.00 | $0 | 28,690 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.